bioRxiv/medRxiv TRiP Review Activity

438 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 10: Articles 91-100  | Next

Δ133p53 and Δ160p53 isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
Zhao, L., Punga, T., Sanyal, S.
10.1101/2024.07.23.604790 — Posted: 2024-07-24 — Discussion: 2025-04-17  eLife
RUNX2 Isoform II Protects Cancer Cells from Ferroptosis by Promoting PRDX2 Expression in Oral Squamous Cell Carcinoma
Huang, J., Jia, R., Guo, J.
10.1101/2024.05.17.594656 — Posted: 2024-05-18 — Discussion: 2025-04-17  eLife
VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300
Guo, S., Hu, X., Cotton, J. L., Ma, L., Li, Q., Cui, J., Wang, Y., Thakare, R. P., Tao, Z., Ip, T., Wu, X., Wang, J., Mao, J.
10.1101/2024.05.01.592016 — Posted: 2024-05-03 — Discussion: 2025-04-14  eLife
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Bhattacharya, A., Stutvoet, T. S., Perla, M., Loipfinger, S., Jalving, M., Reyners, A. K. L., Vermeer, P. D., Drapkin, R., de Bruyn, M., de Vries, E. G. E., de Jong, S., Fehrmann, R. S. N.
10.1101/2024.10.21.619015 — Posted: 2024-10-24 — Discussion: 2025-04-10  eLife
Oncogenic and teratogenic effects of p53Y217C, a mouse model of the human hotspot mutant p53Y220C
Jaber, S., Eldawra, E., Rakotopare, J., Gabriel, M., Lejour, V., Simeonova, I., Morillon, A., Bardot, B., Toledo, F.
10.1101/2024.09.26.615223 — Posted: 2024-09-29 — Discussion: 2025-03-26  eLife
S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting fatty acid metabolism
Huang, H., Yang, Y., Zhang, Q., Yang, Y., Xiong, Z., Mao, S., Song, T., Wang, Y., Liu, Z., Bu, H., Zhang, L., Zhang, L.
10.1101/2024.10.17.618873 — Posted: 2024-10-21 — Discussion: 2025-03-25  eLife
Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma
Purzner, J., Brown, A. S., Purzner, T., Ellis, L., Broski, S., Litzenburger, U., Andrews, K., Sharma, A., Wang, X., Taylor, M. D., Cho, Y.-J., Fuller, M. T., Scott, M. P.
10.1101/2024.11.21.624171 — Posted: 2024-11-21 — Discussion: 2025-03-18  eLife
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Wu, W., Yu, M., Li, Q., Zhao, Y., Zhang, L., Sun, Y., Wang, Z., Gong, Y., Wang, W., Liu, C., Zhang, J., Tang, Y., Xu, X., Guo, X., Zhan, J., Zhang, H.
10.1101/2024.08.01.606147 — Posted: 2024-08-04 — Discussion: 2025-03-18  eLife
Notch signaling maintains a progenitor-like subclass of hepatocellular carcinoma
Seidel, K., Piscol, R., Nguyen, T. T. T., Shelton, A., Cottonham, C., de la Cruz, C. C., Castillo, J., Garcia, J., Segal, E., Merchant, M., Yang, Y. A., Chen, J., Ahmed, M., Scherl, A., Vij, R., Mosteiro, L., Wu, Y., Modrusan, Z., Metcalfe, C., Siebel, C. W.
10.1101/2024.12.13.628320 — Posted: 2024-12-17 — Discussion: 2025-03-05  eLife
In vivo targeted and deterministic single cell malignant transformation
Scerbo, P., Tisserand, B., Delagrange, M., Debare, H., Bensimon, D., Ducos, B.
10.1101/2024.01.30.577941 — Posted: 2024-02-01 — Discussion: 2025-03-05  eLife

Evaluation Sources